Frank Oakes
Director/Board Member chez EDESA BIOTECH, INC.
Fortune : - $ au 31/03/2024
Profil
Frank R.
Oakes was the founder of The Abalone Farm, Inc. (founded in 1976) where he held the title of President & Chief Executive Officer.
He is currently working as an Independent Director at Edesa Biotech, Inc. since 2010.
In the past, he held the position of President & Chief Executive Officer at CAG Capital, Inc. and Stellar Biotechnologies, Inc. He was also the Chairman, President & Chief Executive Officer at Stellar Biotechnologies, Inc. from 2010 to 2019.
Mr. Oakes obtained his undergraduate degree from California Polytechnic State University (San Luis Obispo).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EDESA BIOTECH, INC.
-.--% | 02/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Frank Oakes
| Sociétés | Poste | Début |
|---|---|---|
| EDESA BIOTECH, INC. | Director/Board Member | 01/06/2019 |
Anciens postes connus de Frank Oakes
| Sociétés | Poste | Fin |
|---|---|---|
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Chief Executive Officer | 01/06/2019 |
CAG Capital, Inc.
 CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Chief Executive Officer | 20/04/2010 |
| Stellar Biotechnologies, Inc. /Old/ | Chief Executive Officer | 20/04/2010 |
The Abalone Farm, Inc.
 The Abalone Farm, Inc. Agricultural Commodities/MillingProcess Industries The Abalone Farm, Inc. provides shellfish farming services. The company was founded by John Alexander and Frank R. Oakes in 1976 and is headquartered in Cayucos, CA | Chief Executive Officer | 01/01/1994 |
Formation de Frank Oakes
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EDESA BIOTECH, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Finance |
The Abalone Farm, Inc.
The Abalone Farm, Inc. Agricultural Commodities/MillingProcess Industries The Abalone Farm, Inc. provides shellfish farming services. The company was founded by John Alexander and Frank R. Oakes in 1976 and is headquartered in Cayucos, CA | Process Industries |
| Stellar Biotechnologies, Inc. /Old/ | Health Technology |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
